Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7298242rdf:typepubmed:Citationlld:pubmed
pubmed-article:7298242lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0036087lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0001563lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0014806lld:lifeskim
pubmed-article:7298242lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:7298242pubmed:issue11lld:pubmed
pubmed-article:7298242pubmed:dateCreated1982-1-28lld:pubmed
pubmed-article:7298242pubmed:abstractTextAn improved highly sensitive fluorimetric methods has been employed to measure plasma and saliva levels of erythromycin propionate and stearate in eight healthy volunteers following a single oral dose of 7.5 mg/kg. The plasma curves exhibited a mean half-life of 5.22 +/- s. e. m., 0.86 h-1 for the propionate and 2.97 +/- 0.22 h-1 for the stearate. Peak levels were reached at the 2nd h (4.07 +/- 0.29 microgram/ml for the propionate; 2.15 +/- 0.14 microgram/ml for the stearate). The area under the total plasma concentration curve was about 3-fold higher in the case of propionate. The concentration in saliva was about 20% of the corresponding concentration in plasma for the propionate and about 25% for the stearate. A significant positive correlation was observed between plasma and saliva levels for both macrolides.lld:pubmed
pubmed-article:7298242pubmed:languageenglld:pubmed
pubmed-article:7298242pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7298242pubmed:citationSubsetIMlld:pubmed
pubmed-article:7298242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7298242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7298242pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7298242pubmed:statusMEDLINElld:pubmed
pubmed-article:7298242pubmed:monthNovlld:pubmed
pubmed-article:7298242pubmed:issn0174-4879lld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:BertelliAAlld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:SoldaniGGlld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:BernardiniCClld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:DucciMMlld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:del TaccaMMlld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:ScaloriVVlld:pubmed
pubmed-article:7298242pubmed:authorpubmed-author:GrotheEElld:pubmed
pubmed-article:7298242pubmed:issnTypePrintlld:pubmed
pubmed-article:7298242pubmed:volume19lld:pubmed
pubmed-article:7298242pubmed:ownerNLMlld:pubmed
pubmed-article:7298242pubmed:authorsCompleteYlld:pubmed
pubmed-article:7298242pubmed:pagination494-7lld:pubmed
pubmed-article:7298242pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:meshHeadingpubmed-meshheading:7298242-...lld:pubmed
pubmed-article:7298242pubmed:year1981lld:pubmed
pubmed-article:7298242pubmed:articleTitleThe pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.lld:pubmed
pubmed-article:7298242pubmed:publicationTypeJournal Articlelld:pubmed